Rafael Amado

Rafael Amado

President at ZAI LAB LIMITED

Net worth: 1 M $ as of 31/05/2026

62 year
Health Technology
Consumer Services
Commercial Services

Profile

Presently, Rafael G. Amado occupies the position of Chief Medical Officer, EVP-Research & Development at Allogene Therapeutics, Inc. In the past he was President-Research & Development at Adaptimmune Therapeutics Plc, Senior Vice President at GlaxoSmithKline Plc, Executive Director-Therapeutic Oncology at Amgen Ltd. and Assistant Clinical Professor at the University of California, Los Angeles. Rafael G. Amado received a doctorate from the University of Seville.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
10/04/2026 570,220 ( 0.05% ) 1 M $ 31/05/2026

Rafael Amado active positions

CompaniesPositionStart
ZAI LAB LIMITED President 01/12/2022

Former positions of Rafael Amado

CompaniesPositionEnd
POSEIDA THERAPEUTICS, INC. Director/Board Member 08/01/2025
ALLOGENE THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 30/12/2022
ADAPTIMMUNE THERAPEUTICS PLC Chief Tech/Sci/R&D Officer 12/08/2019
Chief Tech/Sci/R&D Officer 01/07/2019
GSK PLC Corporate Officer/Principal 01/03/2015
See the detail of Rafael Amado's experience

Training of Rafael Amado

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

66

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!